Beximco Pharma gets Scrip Award in London

Beximco Pharma has won the prestigious Scrip Award in the category of ‘Best Company in an Emerging Market’ at the 13th Annual Scrip Awards ceremony held in London recently. 

This is the first time a Bangladeshi company has won this global award which recognizes company’s operational excellence and continued growth in global market.   

Beximco Pharma Chief Operating Officer Rabbur Reza, received the award on behalf of the company. 

The Scrip Awards honour, the highest achieving companies and individuals in global pharma and biotech industry, recognizing their important roles in improving healthcare around the world.

A panel of 16 highly respected and independent judges from across diverse sectors evaluated the award entries to select the finalists, according to a company statement.  

Scrip’s Best Company in an Emerging Market Award seeks to reward the growing R&D-based pharmaceutical company founded in areas beyond its traditional geographic borders of North America, Western Europe and Japan.  Previous winners in this category include globally reputed pharma companies like Dr Reddy’s, Hikma, Glenmark and Mundipharma. 

 “We are setting a high standard for the country’s pharmaceutical industry through our research and development initiatives, strategic partnerships, and expansion programs,” the statement quoted Beximco Pharma Managing Director Nazmul Hassan MP as saying on the occasion.